dipyridamole has been researched along with Tachycardia, Ventricular in 7 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
Excerpt | Relevance | Reference |
---|---|---|
"Ventricular tachycardia is a rare complication of dipyridamole stress testing." | 5.31 | Persistent myocardial ischemia after termination of dipyridamole-induced ventricular tachycardia by intravenous aminophylline: scintigraphic demonstration. ( Chang, WT; Huang, PJ; Lin, LC; Yen, RF, 2000) |
"Ventricular tachycardia is a rare complication of dipyridamole stress testing." | 1.31 | Persistent myocardial ischemia after termination of dipyridamole-induced ventricular tachycardia by intravenous aminophylline: scintigraphic demonstration. ( Chang, WT; Huang, PJ; Lin, LC; Yen, RF, 2000) |
"Reentrant ventricular tachycardia (VT) is known to be insensitive to the nucleoside adenosine." | 1.29 | Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine. Evidence for myocardial receptor-mediated effects. ( Lerman, BB, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saya, S | 1 |
Hennebry, TA | 1 |
Lozano, P | 1 |
Lazzara, R | 1 |
Schechter, E | 1 |
Kobayashi, Y | 1 |
Kikushima, S | 1 |
Tanno, K | 1 |
Kurano, K | 1 |
Baba, T | 1 |
Katagiri, T | 1 |
Lerman, BB | 2 |
Chang, WT | 1 |
Lin, LC | 1 |
Yen, RF | 1 |
Huang, PJ | 1 |
Breuer, HW | 1 |
Chapelon-Abric, C | 1 |
Stein, KM | 1 |
Markowitz, SM | 1 |
Mittal, S | 1 |
Slotwiner, DJ | 1 |
4 reviews available for dipyridamole and Tachycardia, Ventricular
Article | Year |
---|---|
Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature.
Topics: Administration, Oral; Coronary Circulation; Death, Sudden, Cardiac; Dipyridamole; Electrocardiograph | 2008 |
[Ergometry after acute myocardial infarct].
Topics: Adult; Aged; Aged, 80 and over; Atropine; Cardiac Catheterization; Cardiotonic Agents; Dipyridamole; | 2000 |
[Cardiac sarcoidosis].
Topics: Anti-Inflammatory Agents; Biopsy; Cardiomyopathies; Cardiomyopathy, Restrictive; Cardiovascular Agen | 2001 |
Right ventricular outflow tract tachycardia: an update.
Topics: Adenosine; Anti-Arrhythmia Agents; Dipyridamole; Humans; Tachycardia, Ventricular; Ventricular Dysfu | 2002 |
3 other studies available for dipyridamole and Tachycardia, Ventricular
Article | Year |
---|---|
Sustained left ventricular tachycardia terminated by dipyridamole: cyclic AMP-mediated triggered activity as a possible mechanism.
Topics: Acetylcholine; Adolescent; Cardiac Complexes, Premature; Cyclic AMP; Dipyridamole; Electrocardiograp | 1994 |
Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine. Evidence for myocardial receptor-mediated effects.
Topics: Acetylcholine; Adenosine; Adolescent; Adult; Aged; Aminophylline; Catecholamines; Chemoreceptor Cell | 1993 |
Persistent myocardial ischemia after termination of dipyridamole-induced ventricular tachycardia by intravenous aminophylline: scintigraphic demonstration.
Topics: Adult; Aminophylline; Dipyridamole; Humans; Male; Myocardial Ischemia; Radionuclide Imaging; Tachyca | 2000 |